Learn More
BACKGROUND In a phase 2a clinical trial of AN1792 (Study 201), a potential immunotherapeutic agent for use in Alzheimer's disease (AD), approximately 6% of the treated AD patients (18/300) developed(More)
INTRODUCTION Physician payment in the United States will be increasingly tied to quality measurement and performance. Whether participation in quality improvement (QI) through Maintenance of(More)
Since 2005, the American Board of Family Medicine (ABFM) has provided Diplomates with quality improvement tools for meeting the continuing certification Performance in Practice requirement. These(More)